Skip to content
Back Home
Active Life Scientific, Inc.
  • Research Solutions
  • Support
  • Literature
  • Medical
  • Search
Back Home
Active Life Scientific, Inc.
  • Search
  • Research Solutions
  • Support
  • Literature
  • Medical
Home » OsteoProbe » Commentary on Sclerostin Deficiency Is Linked to Altered Bone Composition
OsteoProbe

Commentary on Sclerostin Deficiency Is Linked to Altered Bone Composition

by rpiresearch|Published July 20, 2018

Comment on

  • Sclerostin deficiency is linked to altered bone composition. [J Bone Miner Res. 2014]

https://www.ncbi.nlm.nih.gov/pubmed/25158054

J Bone Miner Res. 2014 Oct;29(10):2141-3. doi: 10.1002/jbmr.2346.

You may also like

Bone Material Properties and Skeletal Fragility
Published July 20, 2018

Bone Material Properties and Skeletal Fragility

Abstract Deformations of vertebrae and sudden fractures of long bones caused by essentially normal loading are a characteristic problem in osteoporosis. If […]

Published July 20, 2018

Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes

Abstract CONTEXT: Skeletal deterioration, leading to an increased risk of fracture, is a known complication of type 2 diabetes mellitus (T2D). Yet […]

Published July 20, 2018

High-Impact Mechanical Loading Increases Bone Material Strength in Postmenopausal Women—A 3-Month Intervention Study

Abstract Bone adapts to loading in several ways, including redistributing bone mass and altered geometry and microarchitecture. Because of previous methodological limitations, […]

Diabetes, Diabetic Complications, and Fracture Risk
Published July 20, 2018

Diabetes, Diabetic Complications, and Fracture Risk

Abstract Diabetes and osteoporosis are both common diseases with increasing prevalences in the aging population. There is increasing evidence corroborating an association […]

Post navigation

  • Previous post Role of donor and host cells in muscle-derived stem cell-mediated bone repair: differentiation vs. paracrine effects
  • Back to post list
  • Next post Review Article: The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes

© 2026 Active Life Scientific, Inc. – All rights reserved

Powered by WP – Designed with the Customizr theme